SCHEMBL24192307

SCHEMBL24192307

CC(C)(C)NOC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8959014 0.96
SCHEMBL21707535 0.67 ALDH1A1 (0.36) TSHRTDP1ALDH1A1
SCHEMBL3890714 0.67
SCHEMBL18630449 0.65 TSHR (0.44) TSHRTDP1
SCHEMBL1149433 0.64
SCHEMBL1938281 0.61
SCHEMBL22338989 0.61
Hydrochloric Acid SCHEMBL15142518 0.61
SCHEMBL18020993 0.61
SCHEMBL5966854 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102131902-A Fatty ester compositions with improved oxidative stability TAMINCO 2011-07-20 CN claimed
US-20230234954-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF TYK MEDICINES, INC. (CN) 2023-07-27 US disclosed
US-20220233513-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF TYK MEDICINES, INC. (CN) 2022-07-28 US disclosed
US-20220009944-A1 ANALOGUES AND DERIVATIVES OF CEPHALOTAXINE AND METHODS FOR MAKING AND USING THE COMPOUNDS OREGON STATE UNIVERSITY (US) 2022-01-13 US disclosed
CN-1550894-B Chemical amplification photo etching glue composition SUMITOMO CHEMICAL CO., LTD. (JP) 2011-11-30 CN disclosed
CN-1550894-A Chemical amplification photo etching glue composition 住友化学工业株式会社 2004-12-01 CN disclosed
CN-1061773-A The preparation of alkoxyalkanoic acids SHELL INT RESEARCH (NL) 1992-06-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234954-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF RET, ROR1, FGFR3 TSHR 1400/4885TDP1 1683/4885ALDH1A1 1813/4885
US-20220009944-A1 ANALOGUES AND DERIVATIVES OF CEPHALOTAXINE AND METHODS FOR MAKING AND USING THE COMPOUNDS SLC6A2, NAPRT, SLC6A3 TSHR 3377/4885TDP1 1054/4885ALDH1A1 1101/4885
US-20220233513-A1 COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF RET, ROR1, FGFR3 TSHR 1339/4885TDP1 1878/4885ALDH1A1 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.